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Introduction 
Results 
• EDMD is a muscle-wasting disorder characterized by muscle 
contracture, progressive muscle wasting, and 
cardiomyopathy (1). 
• EDMD is thought to be caused by improper formation of 
neuromuscular junctions (NMJ)  (2). 
• A proper NMJ requires the positioning of 4-8 synaptic nuclei 
below the synapse (3), which are not present in EDMD 
patients (4). 
• Nuclear positioning in muscle tissue is mediated by the 
LInker of the Nucleus and Cytoskeleton (LINC) complex (5) 
• The LINC complex consists of ONM proteins (nesprins) and 
inner nuclear membrane (INM) proteins (SUNs) that 
physically connect the cytoskeleton to the nucleus. 
• N2G is an ONM actin-binding protein that plays a role in the 
organization of organelles in skeletal muscle cells (6). 
• EDMD patients show a mutation in SYNE2, the gene 
encoding N2G, resulting in the amino acid substitution 
T6211M (7). 
• It is hypothesized that the T6211M mutation inhibits N2G-
dependent nuclear positioning, leading to a lack of synaptic 
nuclei at the NMJ and the pathogenesis of EDMD. 
• This study aims to create wild type and T6211M N2G 
constructs tagged with either GFP, for in vivo analysis of 
N2G subcellular localization and nuclear positioning, or 
tagged with FLAG, for purification and in vitro comparisons 
of wild type vs. T6211M stability and actin affinity. 
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Abstract 
Emery-Dreifuss muscular dystrophy is a muscle-wasting disease 
thought to be caused by improper nuclear positioning in muscle 
fibers. This nuclear positioning is mediated by the outer nuclear 
membrane (ONM) actin-binding protein nesprin-2-giant (N2G). A 
genetic mutation in SYNE2, the gene encoding N2G, has been 
identified in EDMD patients that results in an amino acid 
substitution (T6211M), but its role in EDMD is not understood. This 
study aims to construct wild type and mutant N2G cDNA constructs 
by assembling eleven smaller cDNA fragments and tagging the 
constructs with either green fluorescent protein (GFP) or the FLAG 
sequence for protein purification.  GFP constructs will be used for in 
vivo analysis of how the mutation affects nuclear movement and 
N2G localization. Purified FLAG-tagged proteins will be used for in 
vitro studies to compare wild type and mutant thermal stability and 
actin affinity. During this UROP the eleven N2G cDNA fragments 
were assembled into three larger pieces. To determine if a protein 
lacking the transmembrane KASH domain would localize away 
from the ONM and be suitable for purification, GFP constructs 
encoding the N- and C-terminal domains of N2G and lacking the 
KASH domain were constructed. When expressed in U2OS cells, 
proteins lacking the KASH domain did not localize to the ONM, 
which is essential for purification of full length N2G. Future work 
will aim to finish assembling the three N2G cDNA fragments into 
the full gene to begin studying its role in EDMD pathogenesis. 
 
• The wounded fibroblast monolayer (WFM) system is used to 
study N2G dependent nuclear movement. 
• In the WFM system, 3T3 fibroblasts are cultured in a 
monolayer and serum-starved. A wound is created on the 
monolayer and the serum component lysophosphatidic acid 
(LPA) is added, causing cells at the wound edge to polarize. 
• During polarization a LINC complex-dependent nuclear 
movement occurs, moving the nucleus to the end of the cell 
opposite the wound edge and providing a robust assay for 
LINC complex-dependent nuclear movement. 
• The WFM system has been used to show that mini-N2G, a 
truncated version of N2G containing the Calponin homology 
domains and KASH domain (Figure 1), is sufficient for nuclear 
movement in polarizing fibroblasts (8). 
• Eleven ragments of N2G cDNA were previously cloned into 
plasmids and were present in the Luxton Lab, named A-J and 
core (Figure 1). 
•  During this UROP a GFP-mini-N2G construct was cloned in 
the pcDNA plasmid without the final 74 amino acids of the 
core fragment, which removed the transmembrane KASH 
domain (GFP-mini-N2G-ΔKASH). 
• U20S cells were transfected with this construct using 
Lipofectamine transfection reagent (Life Technologies) and 
analyzed using fluorescence microscopy to see if removal of 
the KASH domain affected localization of GFP-mini-N2G. 
• The eleven N2G cDNA fragments were assembled into a total 
of three larger fragments using Gibson Assembly Cloning 
(New England Biolabs), named X, Y, and Z (Figure 2). 
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• GFP-mini-N2G localized to the nuclear envelope and endoplasmic reticulum in transfected U2OS cells 
• GFP-mini-N2G-ΔKASH was dispersed throughout the cytoplasm, as expected due to the removal of the transmembrane KASH domain 
Figure 3. U2OS cells expressing GFP-mini-N2G and GFP-mini-N2G-ΔKASH. U2OS cells were transfected with GFP-mini-N2G and GFP-mini-N2G-
ΔKASH and observed using fluorescence microscopy. 
• Assemble full-length N2G cDNA from N2G X, Y and Z 
(Figure 2) 
• Create full-length GFP-N2G and FLAG-N2G-ΔKASH 
constructs 
• Introduce the T6211M mutation to both constructs 
• Microinject cDNAs encoding these constructs into the 
nuclei of wound edge NIH3T3 fibroblasts and observe 
localization and ability of each to rescue nuclear 
movement in N2G knockdown cells during cell 
polarization 
• Transfect Sf9 insect cells with wild type and T6211M 
FLAG-N2G-ΔKASH and purify using the FLAG-affinity 
purification system (Sigma Aldrich) 
• Perform circular dichroism spectroscopy on the purified 
proteins and observe and compare the thermal stability of 
wild type and T6211  N2G 
• Perform actin affinity assays on wild type and T6211M 
N2G purified proteins 
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